The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010
Open accessAbstract
IMPORTANCE: Substantial progress has been made in cancer diagnosis and treatment, resulting in a steady improvement in cancer survival. The degree of improvement by age, race, and sex remains unclear. OBJECTIVE: To quantify the degree of survival improvement over time by age, race, and sex in the United States. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal analyses of cancer follow-up data from 1990 to 2010, from 1.02 million patients who had been diagnosed as having cancer of the colon or rectum, breast, prostate, lung, liver, pancreas, or ovary from 1990 to 2009 and who were included in 1 of 9 population-based registries of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program. MAIN OUTCOMES AND MEASURES: Hazard ratios (HRs) and 95% CIs for cancer-specific death were estimated for patients diagnosed as having any of these cancers during 1995 to 1999, 2000 to 2004, and 2005 to 2009, compared with those diagnosed in 1990 to 1994. RESULTS: Significant improvements in survival were found for cancers of the colon or rectum, breast, prostate, lung, and liver. Improvements were more pronounced for younger patients. For patients aged 50 to 64 years and diagnosed from 2005 to 2009, adjusted HRs (95% CIs) were 0.57 (95% CI, 0.55-0.60), 0.48 (95% CI, 0.45-0.51), 0.61 (95% CI, 0.57-0.69), and 0.32 (95% CI, 0.30-0.36), for cancer of the colon or rectum, breast, liver, and prostate, respectively, compared with the same age groups of patients diagnosed during 1990 to 1994. However, the corresponding HRs (95% CIs) for elderly patients (those 75-85 years old) were only 0.88 (95% CI, 0.84-0.92), 0.88 (95% CI, 0.82-0.95), 0.76 (95% CI, 0.69-0.84), and 0.65 (95% CI, 0.61-0.70), for the same 4 cancer sites, respectively. A similar, although weaker, age-related period effect was observed for lung and pancreatic cancers. The adjusted HRs (95% CIs) for lung cancer were 0.75 (95% CI, 0.73-0.77) and 0.84 (95% CI, 0.81-0.86), respectively, for patients aged 50 to 64 years and 75 to 85 years diagnosed between 2005 and 2009, compared with the same age groups of patients diagnosed between 1990 and 1994 (0.73 [95% CI, 0.69-0.77] and 0.90 [95% CI, 0.85-0.95], respectively. Compared with whites or Asians, African Americans experienced greater improvement in prostate cancer survival. From 1990 to 2009, ovarian cancer survival declined among African Americans but improved among whites. No apparent sex difference in the degree of improvement for any non-sex-specific cancer was noted. CONCLUSIONS AND RELEVANCE: Younger patients experienced greater benefit from recent oncology advances than elderly patients. African Americans experienced poorer survival than whites for all cancers, and the racial difference decreased for prostate cancer but increased for ovarian cancer. Identifying factors associated with varied improvement in cancer survival can inform future improvements in cancer care for all.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,140
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
Gill, S., Loprinzi, C. L., Sargent, D. J., Thomé, S. D., Alberts, S. R., Haller, D. G., Benedetti, J., Francini, G., Shepherd, L. E., Francois Seitz, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.059 · Cited by 1,021
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs491 · Cited by 993
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Edwards, B. K., Howe, H. L., Ries, L. A. G., Thun, M. J., Rosenberg, H. M., Yancik, R., Wingo, P. A., Jemal, A., & Feigal, E. G. (2002) · Cancer · doi:10.1002/cncr.10593 · Cited by 880
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. C. (2003) · Cancer · doi:10.1002/cncr.11208 · Cited by 767
Talarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
Cancer Statistics for African Americans
Ghafoor, A., Jemal, A., Cokkinides, V., Cardinez, C., Murray, T., Samuels, A., & Thun, M. J. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.326 · Cited by 549
Sex Disparities in Cancer Mortality and Survival
Cook, M. B., McGlynn, K. A., Devesa, S. S., Freedman, N. D., & Anderson, W. F. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0246 · Cited by 515
Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data
Howlader, N., Ries, L. A. G., Mariotto, A. B., Reichman, M. E., Ruhl, J., & Cronin, K. A. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq366 · Cited by 452
Caillet, P., Canoui-Poitrine, F., Vouriot, J., Berle, M., Reinald, N., Krypciak, S., Bastuji-Garin, S., Culine, S., & Paillaud, E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0664 · Cited by 426
Muss, H. B., Berry, D. A., Cirrincione, C., Budman, D. R., Henderson, I. C., Citron, M. L., Norton, L., Winer, E. P., & Hudis, C. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9710 · Cited by 339
Owusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F., Prout, M., Yood, M. U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304
Winer, E., Gralow, J., Diller, L., Karlan, B., Loehrer, P., Pierce, L., Demetri, G., Ganz, P., Kramer, B., Kris, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2134 · Cited by 293
Cancer statistics for African Americans, 2013
DeSantis, C., Naishadham, D., & Jemal, A. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21173 · Cited by 291
Contemporary Risk Profile of Prostate Cancer in the United States
Shao, Y.-H., Demissie, K., Shih, W., Mehta, A. R., Stein, M. N., Roberts, C. B., DiPaola, R. S., & Lu-Yao, G. L. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp262 · Cited by 269
Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status
Bristow, R. E., Powell, M. A., Al-Hammadi, N., Chen, L., Miller, J. P., Roland, P. Y., Mutch, D. G., & Cliby, W. A. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt065 · Cited by 262
Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?
Gross, C. P., Smith, B. D., Wolf, E., & Andersen, M. (2008) · Cancer · doi:10.1002/cncr.23228 · Cited by 246
Impact of Comorbidity on Chemotherapy Use and Outcomes in Solid Tumors: A Systematic Review
Lee, L., Cheung, W. Y., Atkinson, E., & Krzyzanowska, M. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3049 · Cited by 237
Harper, S., Lynch, J., Meersman, S. C., Breen, N., Davis, W. W., & Reichman, M. C. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0679 · Cited by 221
van de Water, W., Markopoulos, C., van de Velde, C. J. H., Seynaeve, C., Hasenburg, A., Rea, D., Putter, H., Nortier, J. W. R., de Craen, A. J. M., Hille, E. T. M., et al. (2012) · JAMA · doi:10.1001/jama.2012.84 · Cited by 200
Racial Disparities in Stage-Specific Colorectal Cancer Mortality Rates From 1985 to 2008
Robbins, A. S., Siegel, R. L., & Jemal, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.5527 · Cited by 198
Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades
Barnholtz-Sloan, J. S., Schwartz, A. G., Qureshi, F., Jacques, S., Malone, J., & Munkarah, A. R. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00579-9 · Cited by 196
Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer
Freedman, R. A., He, Y., Winer, E. P., & Keating, N. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9234 · Cited by 159
Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?
Smith, B. D., Jiang, J., McLaughlin, S. S., Hurria, A., Smith, G. L., Giordano, S. H., & Buchholz, T. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.8408 · Cited by 155
Social and Racial Differences in Selection of Breast Cancer Adjuvant Chemotherapy Regimens
Griggs, J. J., Culakova, E., Sorbero, M. E. S., Poniewierski, M. S., Wolff, D. A., Crawford, J., Dale, D. C., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2749 · Cited by 149
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
Shayne, M., Culakova, E., Poniewierski, M. S., Wolff, D. A., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.22939 · Cited by 145
Pancreatic Cancer Death Rates by Race Among US Men and Women, 1970–2009
Ma, J., Siegel, R. L., & Jemal, A. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt292 · Cited by 145
How Does Older Age Influence Oncologists' Cancer Management?
Foster, J. A., Salinas, G. D., Mansell, D., Williamson, J. C., & Casebeer, L. L. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0198 · Cited by 135
Jafari, M. D., Jafari, F., Halabi, W. J., Nguyen, V., Pigazzi, A., Carmichael, J. C., Mills, S., & Stamos, M. J. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.4930 · Cited by 128
Recent Trends in Black-White Disparities in Cancer Mortality
DeLancey, J. O., Thun, M. J., Jemal, A., & Ward, E. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0131 · Cited by 122
Hershman, D. L., Unger, J. M., Barlow, W. E., Hutchins, L. F., Martino, S., Osborne, C. K., Livingston, R. B., & Albain, K. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1163 · Cited by 119
Survival Disparities in Non–Small Cell Lung Cancer by Race, Ethnicity, and Socioeconomic Status
Tannenbaum, S. L., Koru‐Sengul, T., Zhao, W., Miao, F., & Byrne, M. M. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000058 · Cited by 119
Herbst, R. S., Bajorin, D. F., Bleiberg, H., Blum, D., Hao, D., Johnson, B. E., Ozols, R. F., Demetri, G. D., Ganz, P. A., Kris, M. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8678 · Cited by 119
Clarke, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl238 · Cited by 101
Taylor, K. L., Davis, J. L., Turner, R. O., Johnson, L., Schwartz, M. D., Kerner, J. F., & Leak, C. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0417 · Cited by 99
Gralow, J. R., Ozols, R. F., Bajorin, D. F., Cheson, B. D., Sandler, H. M., Winer, E. P., Bonner, J., Demetri, G. D., Curran, W., Ganz, P. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4088 · Cited by 89
Zak, Y., Rhoads, K. F., & Visser, B. C. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.37 · Cited by 87
Pharmacokinetics and Toxicity of Weekly Docetaxel in Older Patients
Hurria, A., Fleming, M. T., Baker, S. D., Kelly, W. K., Cutchall, K., Panageas, K. S., Caravelli, J. F., YEUNG, H. W. D., Kris, M. G., Gomez, J. E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0200 · Cited by 84
Sex Disparities in Cancer Mortality: The Risks of Being a Man in the United States
Najari, B. B., Rink, M., Li, P. S., Karakiewicz, P. I., Scherr, D. S., Shabsigh, R., Meryn, S., Schlegel, P. N., & Shariat, S. F. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.153 · Cited by 48
Aranda, M. A., McGory, M. L., Sekeris, E., Maggard, M. A., Ko, C. Y., & Zingmond, D. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.009 · Cited by 46
Wong, R. J., & Corley, D. A. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0661-8 · Cited by 45
Castleberry, A. W., Güller, U., Tarantino, I., Berry, M. F., Brügger, L. E., Warschkow, R., Cerny, T., Mantyh, C. R., Candinas, D., & Worni, M. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-014-2515-3 · Cited by 22
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,546
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Metadata
- Authors
- Zeng, C., Wen, W., Morgans, A. K., Pao, W., Shu, X.-O., & Zheng, W.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2015-04-01
- Volume
- 1
- Issue
- 1
- Pages
- 88
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2112644144
- Cited by
- 321
- References
- 53
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.